Moon Surgical, a French-American pioneer in collaborative robotics, announced today that it has secured $55.4 million in additional funding to support the continued development and planned commercialization of its Maestro System.


Moon Surgical, a French-American pioneer in collaborative robotics, announced today that it has secured $55.4 million in additional funding to support the continued development and planned commercialization of its Maestro System.

 

This most recent financing was co-led by Sofinnova Partners, through its Sofinnova Capital Strategy, and NVIDIA's venture capital arm, NVentures, with participation from Fred Moll, MD, and Josh Makower, MD. Also joining the round were existing investors GT Healthcare Capital, Cathay Health, Johnson & Johnson Innovation - JJDC, and Sofinnova Partners' MD Start, as well as Yann Fleureau, Siddarth Satish, Sacha Loiseau, and Richard Leparmentier. With the funding, Moon Surgical also announced the appointment of Fred Moll, MD, as an independent Chair of the Board.

 

The financing round comes on the heels of the company's other notable accomplishments, which include Maestro's CE Mark this past April, and 510(k) clearance in December of 2022.


https://www.accesswire.com/755304/Moon-Surgical-Appoints-Fred-Moll-MD-as-Board-Chair-and-Raises-Additional-554-Million-in-New-Funding-with-Leading-Investors-Sofinnova-Partners-and-NVIDIA